Autres langues AstraZeneca PLC Deutsche Boerse AG

Actions

ZEG

GB0009895292

Produits pharmaceutiques

Marché Fermé - Deutsche Boerse AG Autres places de cotation 21:17:55 23/07/2026			Varia. 5j.	Varia. 1 janv.
149,00 ^EUR	+0,20 %		+1,43 %	-5,87 %

23/07	Les bourses européennes clôturent en forte baisse jeudi ; la Banque centrale européenne maintient ses taux inchangés	MT
23/07	Les ETF et les contrats à terme sur actions en baisse avant l'ouverture jeudi, plombés par les valeurs technologiques	MT

Autres langues

23/07	Healthcare Shares Rise on Optimism Around Weight Loss Drugs -- Health Care Roundup
23/07	European Stocks Close Sharply Lower in Thursday Trading; European Central Bank Leaves Rates Unchanged
23/07	Royalty Pharma acquires royalty interest in AstraZeneca's cliramitug for up to $425 million from Neurimmune
23/07	Neurimmune sells a portion of its royalty interest in cliramitug to Royalty Pharma
23/07	Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Major Tech Stocks Sell-Off
23/07	Defensieaandelen in trek op rode Europese beursvloeren
23/07	European Midday Briefing : Oil Hits $98 a Barrel, Shares Fall Ahead of ECB Decision
23/07	AstraZeneca's Etcamah combo approved for breast cancer treatment in EU
23/07	Astrazeneca's Etcamah combination for ESR1-mutated advanced breast cancer
23/07	Oil Tops $98 a Barrel, Tech Earnings Worry Markets
23/07	AstraZeneca Wins EU Approval for Breast-Cancer Drug as U.S. Review Continues
23/07	AstraZeneca's Etcamah Combination Wins EU Approval for Breast Cancer
23/07	Hair loss with GLP-1 drugs is rare, but real, studies find
22/07	What Bundibugyo Ebola vaccines and treatments are under development
22/07	Royalty Pharma Acquires Royalty Interest in AstraZeneca's Cliramitug
21/07	Mitie acepta una opa de 4.200 millones de dólares de su competidora OCS y se dispara en bolsa
21/07	Novartis backs full year forecast after $6 billion profit beat helped by one-offs
20/07	European Stocks Close Mixed in Monday Trading; Energy Stocks Rise Amid Expanding Middle East Fighting
20/07	AstraZeneca Unit Highlights Opportunities in Rare Diseases
20/07	Novartis faces drug pipeline test with valuation premium in focus
20/07	Could AI chip boom make ASML Europe's first trillion-dollar firm?
17/07	WOCHENVORSCHAU/27. Juli bis 1. August (31. KW)
16/07	Illumina, Inc., Formation Bio, Astrazeneca, Merck, and Eli Lilly and Company Expand Billion Cell Atlas Alliance with New Ai Drug Developers
16/07	Molecular Partners Doses First Patients in Phase 2 Study of Biliary Tract Cancer Therapy
16/07	Keymed Biosciences Expects Return to Profit in H1